California Public Employees Retirement System’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-534
Closed -$8K 3482
2016
Q3
$8K Hold
534
﹤0.01% 3470
2016
Q2
$18K Hold
534
﹤0.01% 3520
2016
Q1
$13K Hold
534
﹤0.01% 3556
2015
Q4
$27K Hold
534
﹤0.01% 3548
2015
Q3
$96K Hold
534
﹤0.01% 3405
2015
Q2
$76K Hold
534
﹤0.01% 3531
2015
Q1
$83K Hold
534
﹤0.01% 3627
2014
Q4
$83K Hold
534
﹤0.01% 3627
2014
Q3
$128K Hold
534
﹤0.01% 3528
2014
Q2
$234K Hold
534
﹤0.01% 3365
2014
Q1
$236K Hold
534
﹤0.01% 3330
2013
Q4
$257K Hold
534
﹤0.01% 3221
2013
Q3
$257K Sell
534
-7
-1% -$3.35K ﹤0.01% 3080
2013
Q2
$254K Buy
+541
New +$245K ﹤0.01% 3008

Other funds holding IDXG

California Public Employees Retirement System's IDXG Position: Q4 2016 in Review

California Public Employees Retirement System sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q4 2016, closing a stake of 534 shares — an estimated $8K sold.

California Public Employees Retirement System first reported a position in IDXG in Q2 2013 and held it in 14 quarters. The position peaked at $257K in Q4 2013. 14 funds tracked by Wall St. Rank hold IDXG as of Q4 2016.

  • California Public Employees Retirement System reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • California Public Employees Retirement System sold 534 Interpace Biosciences, Inc. Common Stock shares in Q4 2016, an estimated $8K.
  • California Public Employees Retirement System first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 14 quarters.
  • California Public Employees Retirement System's Interpace Biosciences, Inc. Common Stock position peaked at $257K in Q4 2013.
  • 14 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2016.

Based on California Public Employees Retirement System's 13F filing for Q4 2016, filed 10 Feb 2017.